Wednesday - ARVO

5028 – 5049 – Wednesday – Posters
Wednesday Posters
2:45 pm – 4:30 pm
5028 — A0190 Relationship between
Visual Function and Optical Coherence
Tomography features in Early Age-related
macular degeneration (AMD)-Early Markers
Observational Study. Ruth E. Hogg 1 , G. Murphy 1 ,
G. Staurenghi 2 , C. Rosina 2 , R. Silva 3 , A. Santos 3 ,
U. Chakravarthy 1 . 1 Center for Vision and Vascular
Science, Queen’s University Belfast, Belfast, United
Kingdom; 2 Eye Clinic - Department of Clinical
Science, “Luigi Sacco”- Sacco Hospital, II School
of Ophthalmology - University of Milan, Milan,
Italy; 3 Faculty of Medicine., University of Coimbra,
Coimbra, Portugal *CR
5029 — A0191 Relationship between retinal
sensitivity and retinal thickness in eyes with
retinal disease. Srinivas R. Sadda, M. Nittala.
Ophthalmology, Doheny Eye Institute - USC, Los
Angeles, CA *CR
5030 — A0192 Multimodal Evaluation of
Macular Function in Age-related Macular
Degeneration. Ken Ogino, A. Tsujikawa, K.
Yamashiro, S. Ooto, A. Oishi, I. Nakata, M. Miyake,
A. Takahashi, A. A. Ellabban, N. Yoshimura. Kyoto
University Graduate School of Medicine, Kyoto,
Japan *CR
5031 — A0193 The functional impact of
subfoveal SD-OCT characteristic on reading
acuity in neovascular age related macular
degeneration. Florian Sulzbacher 1 , C. G. Kiss 1 , S.
Sacu 1 , M. R. Munk 1 , A. Kaider 2 , T. Mittermueller 1 , P.
K. Roberts 1 , U. Schmidt-Erfurth 1 . 1 Ophthalmology,
Medical University Vienna, Vienna, Austria; 2 Center
for Medical Statistics, Informatics, and Intelligent
Systems; Section for Clinical Biometrics;, Medical
University of Vienna, Vienna, Austria *CR
5032 — A0194 Dark-adapted Microperimetry
In Age-related Maculopathy And Geographic
Atrophy. Michael D. Crossland 1, 2 , R. Ba-Abbad 1, 2 ,
S. Degli Esposti 2 , A. Tufail 2, 3 , G. S. Rubin 1, 3 .
1
UCL Institute of Ophthalmology, London,
United Kingdom; 2 Moorfields Eye Hospital NHS
Foundation Trust, London, United Kingdom;
3
NIHR Moorfields Biomedical Research Centre for
Ophthalmology, London, United Kingdom *CR
5033 — A0195 Development of a Dark
Adaptation Protocol for Use in AMD Clinical
Trials. Gregory R. Jackson 1 , J. G. Edwards 2 .
1
Ophthalmology, Penn State College of Medicine,
Hershey, PA; 2 MacuLogix, Hershey, PA *CR
5034 — A0196 High Angular Resolution
Peripheral Refraction in Patients with Age
Related Macular Degeneration. Bart Jaeken 2, 1 ,
E. Alcón 1, 3 , J. Marín 3 , P. Artal 1 . 1 Laboratorio de
Optica, Universidad de Murcia, Murcia, Spain;
2
R&D, Voptica, Murcia, Spain; 3 Oftalmología,
Hospital Virgen de la Arrixaca, Murcia, Spain *CR
5035 — A0197 Compensation of fixational
instability by the NIDEK MP-1 micro-perimeter.
Arunkumar Krishnan, H. E. Bedell. University of
Houston - College of Optometry, Houston, TX
5036 — A0198 BCEA evaluation after pattern
stimulation in wet AMD patients. Enzo M.
Vingolo, P. G. Limoli, S. Fragiotta, V. De Rosa, D.
Domanico. UOC Ophthal Hosp “SM Goretti” LT,
University La Sapienza of Rome, Roma, Italy
5037 — A0199 The Influence of Fixation
Stability on Balance in Patients with a Central
Scotoma. Caitlin Murphy 1, 4 , J. Chu 2 , E. Landy 2 ,
J. Campbell 2 , A. Phan 2 , O. Overbury 1, 3 . 1 School
of Optometry, University of Montreal, Montreal,
QC, Canada; 2 Physiotherapy, McGill University,
Montreal, QC, Canada; 3 Ophthalmology, McGill
University, Montreal, QC, Canada; 4 Centre for
Interdisciplinary Research in Rehabilitation (CRIR),
Montreal, QC, Canada
5038 — A0200 Impact of Visual Motion
Displayed in a Non-Immersive Head-Mounted
Device on the Balance of Patients with Age-
Related Macular Degeneration. Caroline
Chauvire 1 , C. Cecilia 1 , A. Koustanai 1 , J. Le Brun 1 ,
S. Pineau 1 , T. Villette 2 , P. Chaumet-Riffaud 1, 3 ,
S. Mohand-Said 1 , J. A. Sahel 1 , A. B. Safran 1 .
1
INSERM, U968; UPMC Univ Paris 06, UMR_S
968, Institut de la Vision; CNRS, UMR_7210;
CHNO des Quinze-Vingts, INSERM-DHOS CIC
503, Paris, France; 2 Essilor R&D International,
Paris, France; 3 Univ Paris Sud, AP-HP, CHU
Bicêtre, Paris, France *CR
5039 — A0201 Comparing the fixational and
functional preferred retinal locus. Brian Sullivan,
L. Renninger. Smith-Kettlewell Eye Research
Institute, San Francisco, CA
5040 — A0202 Maximum Reading Speed and
Binocular Summation in Patients with Central
Vision Loss. Luminita Tarita-Nistor 1, 2 , E. G.
Gonzalez 1, 2 , M. H. Brent 3, 4 , S. N. Markowitz 3, 4 , M.
J. Steinbach 1, 2 . 1 Vision Science Research Program,
Toronto Western Hospital, Toronto, ON, Canada;
2
Centre for Vision Research, York University,
Toronto, ON, Canada; 3 Ophthalmology and
Vision Sciences, University of Toronto, Toronto,
ON, Canada; 4 Ophthalmology, Toronto Western
Hospital, Toronto, ON, Canada
5041 — A0203 Predictive Factors of Reading
Performance Post Reading Rehabilitation
Program in Central Field Loss Patients.
Salvatore Di Lauro, M. B. Coco, A. López-Miguel,
R. Cuadrado, A. Mayo, J. De Lázaro, M. J.
Maldonado, J. Herrera, L. Mena, J. Pastor. Retina-
Low Vision, IOBA Eye Institute, University of
Valladolid, Valladolid, Spain *CR
5042 — A0204 Do Pedestrians Make Safe
Street-Crossing Decisions? Shirin E. Hassan.
School of Optometry, Indiana University,
Bloomington, IN
Exhibit Hall B0001-B0033
Wednesday, May 08, 2013 2:45 PM-4:30 PM
Physiology/Pharmacology
468 Drug Delivery III
Moderators: Ashim K. Mitra and
Uday B. Kompella
5043 — B0001 A minimally invasive and
localised intra-scleral delivery of drug-loaded
thermoresponsive polymeric implants to treat
posterior ocular diseases. Hannah L. McMillan,
S. J. Fallows, T. R. Singh, D. S. Jones. School of
Pharmacy, Queen’s University Belfast, Belfast,
United Kingdom *CR
5044 — B0002 Hindered convective transport
of nanoparticles and macromolecules in
the vitreous humor. Anita N. Penkova 1, 2 , K.
Rattanakijsuntorn 1 , Y. Tang 2 , R. Moats 2, 3 , M. R.
Robinson 4, 2 , S. S. Lee 4, 2 , S. S. Sadhal 1, 2 . 1 Aerospace
& Mechanical Engineering, University of Southern
California, Los Angeles, CA; 2 SAIRC, Saban
Research Center, Children’s Hospital Los Angeles,
Los Angeles, CA; 3 Biomedical Engineering,
University of Southern California, Los Angeles,
CA; 4 Global Pharmaceutical Sciences, Allergan,
Inc, Irvine, CA *CR
5045 — B0003 Slow-release intraocular drug
delivery by injectable PEA microfibrils (DSM,
NL). Gabriele Thumann 1 , G. Mihov 2 , J. Thies 2 , A.
Kemp 2 , K. Morawa 1 , M. Kropp 1 . 1 Department of
Ophthalmology, University of Geneva, Geneva,
Switzerland; 2 DSM, Geleen, Netherlands *CR
5046 — B0004 Fucoidan but not Mannan
inhibits Bevacizumab uptake independently
of phagocytosis and reduces VEGF expression
in the RPE. Michaela Dithmer 1 , T. Meyer 2, 3 ,
E. Richert 1 , J. Roider 1 , A. K. Klettner 1 .
1
Ophthalmology, University of Kiel, University
Medical Center, Kiel, Germany; 2 Immunology,
University of Kiel, University Medical Center, Kiel,
Germany; 3 Medizinische Klinik I, Charite-Campus
Benjamin Franklin, Berlin, Germany *CR
5047 — B0005 In Vivo Pharmacokinetics
of Injectable, Intravitreal, Sustained-Release
Latanoprost Formulations. William S. White, M.
Hu, G. Huang, T. Pham, F. Karasina, A. Lee, M.
Gorlina, V. Wong. Icon Bioscience, Inc, Sunnyvale,
CA *CR
5048 — B0006 Hystem, a bio-absorbable
protein delivery polymer: safety, tolerability and
efficacy in a rabbit corneal debridement model.
MaryJane Rafii 1 , B. M. Wirostko 1, 2 , L. Werner 2 , N.
Mamalis 2 , T. Zarembinski 4 , S. Pritt 3 , G. G. Gum 3 .
1
Ophthalmics, Jade Therapeutics, Salt Lake City,
UT; 2 Ophthalmology, University of Utah, SLC, UT;
3
Absorption Systems, SD, CA; 4 BioTime, Almeda,
CA *CR
5049 — B0007 Delivery of Human Growth
Hormone via DSM’s Poly(ester amide). Julien
Bérard 1 , J. Zupancich 1 , A. Hecka 1 , G. Mihov 1 , S.
Reiver 1 , J. Thies 1 , K. A. Messier 1 , B. M. Wirostko 2 ,
M. Rafii 2 . 1 DSM, Geleen, Netherlands; 2 Jade
Therapeutics, LLC, Salt Lake City, UT *CR
The Commercial Relationships (CR) Index for Disclosures and the Clinical Trial (CT) Registration Index are at arvo.org/2013/ProgramSummary/Index.
324